2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

AMPK signalling in health and disease

D Carling - Current opinion in cell biology, 2017 - Elsevier
In eukaryotic cells AMP-activated protein kinase (AMPK) plays a major role in regulating
cellular energy balance. AMPK responds to changes in intracellular adenine nucleotide …

[PDF][PDF] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

PM Elliott, A Anastasakis, MA Borger… - Polish Heart …, 2014 - journals.viamedica.pl
Kardiomiopatie definiuje się jako strukturalne oraz funkcjonalne nieprawidłowości mięśnia
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …

Recommendations for interpretation of 12-lead electrocardiogram in the athlete

D Corrado, A Pelliccia, H Heidbuchel… - European heart …, 2010 - academic.oup.com
Cardiovascular remodelling in the conditioned athlete is frequently associated with
physiological ECG changes. Abnormalities, however, may be detected which represent …

PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis

SM Schultze, BA Hemmings, M Niessen… - Expert reviews in …, 2012 - cambridge.org
New therapeutic approaches to counter the increasing prevalence of obesity and type 2
diabetes mellitus are in high demand. Deregulation of the phosphoinositide-3-kinase …

Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial …

P Charron, M Arad, E Arbustini, C Basso… - European heart …, 2010 - academic.oup.com
Advances in molecular genetics present new opportunities and challenges for cardiologists
who manage patients and families with cardiomyopathies. The aims of this position …

PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) …

MI Cohen, JK Triedman, BC Cannon… - Heart …, 2012 - heartrhythmjournal.com
Wolff-Parkinson-White (WPW) electrocardiographic (ECG) pattern. 1 The terminology WPW
was first used to describe a “bundle-branch pattern” with a short PR interval in healthy young …

Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry

SD Colan, SE Lipshultz, AM Lowe, LA Sleeper… - Circulation, 2007 - Am Heart Assoc
Background—Current information on the epidemiology and outcomes of hypertrophic
cardiomyopathy (HCM) in children is limited by disease diversity and small case series …

A modern approach to the treatment of mitochondrial disease

S Parikh, R Saneto, MJ Falk, I Anselm… - … treatment options in …, 2009 - Springer
Opinion statement The treatment of mitochondrial disease varies considerably. Most experts
use a combination of vitamins, optimize patients' nutrition and general health, and prevent …

AMP-activated protein kinase in the heart: role during health and disease

M Arad, CE Seidman, JG Seidman - Circulation research, 2007 - Am Heart Assoc
AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that is expressed in most
mammalian tissues including cardiac muscle. Among the multiple biological processes …